Today: 27 January 2026
Subscribe
Browse Category

Legal News News 2 December 2025 - 7 December 2025

Perplexity AI in the Spotlight: NYT Lawsuit, Cristiano Ronaldo Investment and New Security Tech – Everything That Happened From 5–7 December 2025

Perplexity AI in the Spotlight: NYT Lawsuit, Cristiano Ronaldo Investment and New Security Tech – Everything That Happened From 5–7 December 2025

Over just three days, Perplexity AI – the fast‑growing “answer engine” positioned as a challenger to Google – has been hit by a major copyright lawsuit from The New York Times, celebrated a headline‑grabbing investment from Cristiano Ronaldo, rolled out a new browser security system, and expanded its reach in India through free premium bundles. Here’s a detailed look at…
7 December 2025
··
PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

As of December 7, 2025, PDD Holdings Inc. – the Dublin‑based parent of Chinese e‑commerce platform Pinduoduo and global bargain marketplace Temu – is back in the headlines. Strong third‑quarter earnings, fresh regulatory scrutiny in the United States and Europe, and a wave of new analyst forecasts have all converged to make PDD Holdings Inc – ADR (NASDAQ: PDD) one…
7 December 2025
····
DiDi Global Stock (DIDIY) on 7 December 2025: Robotaxi Breakthrough, Lawsuit Settlement and Hong Kong IPO Buzz

DiDi Global Stock (DIDIY) on 7 December 2025: Robotaxi Breakthrough, Lawsuit Settlement and Hong Kong IPO Buzz

Updated: 7 December 2025 – This article is for information only and is not investment advice. DiDi Global Inc., the Chinese ride‑hailing giant once at the center of Beijing’s tech crackdown, is back in the spotlight. In late 2025 the stock is trading in the mid‑$5 range on the U.S. over‑the‑counter market under the ticker DIDIY, with improving profits, a…
7 December 2025
····
CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Health Corp (NYSE: CVS) is back in the spotlight. As of December 6, 2025, CVS stock is trading around $75.60 per share, following a powerful 2025 rally but also a wave of fresh legal settlements, a major goodwill write‑down and renewed questions about its clinic strategy. At the same time, management has raised 2025 profit guidance, is signaling double‑digit…
6 December 2025
···
Johnson & Johnson Stock Today (JNJ): Price, Talc Verdicts, New Bladder Cancer Data and 2026 Outlook – December 6, 2025

Johnson & Johnson Stock Today (JNJ): Price, Talc Verdicts, New Bladder Cancer Data and 2026 Outlook – December 6, 2025

Published: December 6, 2025 – For information only, not investment advice. Johnson & Johnson stock (NYSE: JNJ) is ending the first week of December 2025 just below record territory after a powerful year-long rally, driven by a string of earnings beats, major acquisitions in neuroscience and oncology, and fresh clinical data in bladder cancer. At the same time, the company…
6 December 2025
····
DJT Stock Price Today (December 6, 2025): Trump Media Near 52‑Week Lows as Crypto Bets and Legal Truce Shape the Story

DJT Stock Price Today (December 6, 2025): Trump Media Near 52‑Week Lows as Crypto Bets and Legal Truce Shape the Story

Trump Media & Technology Group Corp. (NASDAQ: DJT), the company behind Truth Social, continues to trade near the bottom of its 2025 range after a year of extreme volatility, widening losses, and an aggressive pivot into crypto and “America First” financial products. As of the close on December 5, 2025, DJT stock finished at $11.36, down 3.65% on the day.…
6 December 2025
···
Wilmar International (SGX:F34) Stock Outlook – Legal Headwinds, Earnings Rebound and a 4.6% Dividend Yield (5 December 2025)

Wilmar International (SGX:F34) Stock Outlook – Legal Headwinds, Earnings Rebound and a 4.6% Dividend Yield (5 December 2025)

As of mid‑day on 5 December 2025, Wilmar International Limited (SGX:F34) is trading around S$3.03–S$3.06 per share on the Singapore Exchange, after several weak sessions that have pulled the stock down roughly 6% over the last 10 trading days. SG Investors Despite that near‑term pressure, the agribusiness giant still offers a trailing dividend yield of about 4.6%, based on total…
5 December 2025
····
Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

As of the close on December 4, 2025, Merck & Co., Inc. (NYSE: MRK) shares finished at $100.86, down about 1.4% on the day, with after‑hours trading essentially flat around $100.83. The stock sits near the upper end of its 52‑week range of $73.31–$105.84, with a market value of roughly $250 billion, a trailing P/E around 13.3 and a forward…
4 December 2025
···
Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

As of December 4, 2025, Bristol Myers Squibb Company (NYSE: BMY) is back on the radar of growth, value and dividend investors. After a sharp rally this week driven by fresh news on its Alzheimer’s drug Cobenfy, an AI-enabled drug discovery milestone and a high‑stakes lawsuit ruling, BMY stock is trading around $50.55, giving the U.S. pharma giant a market…
4 December 2025
····
Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

The Mumbai Suburban District Consumer Disputes Redressal Commission has directed Niva Bupa Health Insurance Company Ltd to pay ₹66.5 lakh to a Juhu-based cancer patient after holding that the insurer wrongfully cancelled his policy and denied his overseas treatment claim. The order, now widely reported across legal and financial media as of December 4, 2025, is being described as one…
4 December 2025
·
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

As of early December 3, 2025, Elevance Health, Inc. (NYSE: ELV) is trading around $331 per share, leaving the managed-care giant roughly 30% below its 52‑week high near $459, even after a strong third‑quarter earnings beat and renewed institutional buying. Investing Over the past 12 months the stock is down about 18%, significantly lagging the S&P 500. PortfoliosLab This article…
3 December 2025
···
Costco (COST) Stock on December 2, 2025: Tariff Lawsuit, Membership Engine and 2026 Price Targets

Costco (COST) Stock on December 2, 2025: Tariff Lawsuit, Membership Engine and 2026 Price Targets

Updated December 2, 2025 Costco Wholesale Corporation (NASDAQ: COST) is starting December with more headlines than usual. The warehouse-club giant is suing the U.S. government over Trump-era tariffs, fine‑tuning its powerful membership model and preparing for a key earnings report — all while its richly valued stock lags the market. Here’s a comprehensive roundup of the latest Costco stock news,…
2 December 2025
····
1 … 6 7 8 9 10 … 12

Stock Market Today

  • Talon Metals Director Henri Van Rooyen Sells 82,200 Shares
    January 27, 2026, 6:39 AM EST. Talon Metals Corp. (TSE:TLO) director Henri Van Rooyen sold 82,200 shares at an average price of C$6.20 on December 29, marking a 15.79% reduction in his stake to 438,524 shares. The sale totaled C$509,640. Van Rooyen executed multiple other trades the same day, including sales at varied prices and volumes, with some transactions showing inconsistencies in reported prices. Talon Metals opened at C$0.66 on Tuesday, within a 52-week range of C$0.08 to C$0.70. The company, which develops mineral assets in the U.S. and Brazil, has a market cap of approximately C$975.65 million and a P/E ratio of -55.00, reflecting ongoing exploration and development operations.
Go toTop